Carlos Campoy is the founder of CytomX Therapeutics. Latest round: Series B. Backed by Third Rock Ventures, Roche Venture Fund.
Carlos Campoy was appointed as Senior Vice President and Chief Financial Officer at CytomX Therapeutics on March 23, 2020. He brings over 30 years of financial and leadership experience, primarily from publicly held companies within the healthcare and biopharmaceutical sectors. Prior to CytomX, he held CFO and senior finance roles at Alder BioPharmaceuticals, Allergan plc, and Eli Lilly and Company.
Full founder directory · Investor directory · Company funding database · Fundraising library